Morning Market Losers
July 01, 2014 at 09:46 AM EDT
Synageva BioPharma (NASDAQ: GEVA) shares tumbled 8.22% to $96.19 after the company reported that Phase 3 study met primary endpoint and ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.